About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNANCT04722705

Combined Intense Pulsed Light (IPL) With Fractional Erbium:YAG Laser Ablation in Scar Prevention

The scar site was divided into 3 sites; combined IPL/fractional Er:YAG laser treatment site, fractional Er:YAG laser treatment site and untreated control site. At baseline, three lesions were randomiz...

Lead sponsor: Hallym University Kangnam Sacred Heart Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Contacts

Bo Young Chung, M.D., PhD

CONTACT

+82-10-8940-4343 victoryby@naver.com

Sponsors

Lead Sponsor

Hallym University Kangnam Sacred Heart Hospital

Age

20 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Clinical diagnosis of postoperative scars on the abdomen
•scars were symmetrical shaped in a line of 3cm or more

Exclusion Criteria

•uncontrolled systemic or chronic disease
•hypersensitive to the ingredients
•a history of other laser treatments within the past 6 months
•pregnancy
•lactation
•Recent sun exposure

Related studies

COMPLETEDPhase 2

Safety and Efficacy Study of Different Dose Levels of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty

NCT01038297 · Scar Prevention

COMPLETEDPhase 2

A Study to Evaluate the Safety and Efficacy of Additional Doses of AZX100 Drug Product Following Excision of Keloid Scars

NCT00892723 · Scar Prevention, Scar Reduction

COMPLETEDPhase 2

A Phase 2a Study to Evaluate the Safety and Efficacy of AZX100 in Trocar Sites of Arthroscopic Shoulder Surgery Patients

NCT00811577 · Scar Prevention, Scar Reduction

COMPLETEDPhase 2

A Study to Evaluate the Safety and Efficacy of AZX100 Drug Product Following Excision of Keloid Scars

NCT00825916 · Scar Prevention, Scar Reduction

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 26, 2021Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment30

Start dateJan 2020

Last updatedJan 26, 2021

Condition

Intense Pulsed Light Erbium-yttrium Aluminum Garnet Laser Scar Prevention

Locations shown

Kangnam Sacred Heart Hospital

Seoul

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 26, 2021Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions